Clinical Trial Update: Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAFLD [Phase 2]

View source ↗

Summary

Phase 2a clinical trial update evaluating the safety, tolerability, and efficacy of TLC-2716 in adults with hypertriglyceridemia and nonalcoholic fatty liver di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia
• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• TLC-2716

Snippet

Sponsor: OrsoBio, Inc | Conditions: Hypertriglyceridemia, Nonalcoholic Fatty Liver Disease | Phase 2 | Status: RECRUITING